ESMERON

This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug ESMERON contains one active pharmaceutical ingredient (API):

1 Rocuronium UNII I65MW4OFHZ - ROCURONIUM BROMIDE

Rocuronium is a fast onset, intermediate acting non-depolarising neuromuscular blocking agent, possessing all of the characteristic pharmacological actions of this class of medicinal products (curariform agents). It acts by competing for nicotinic cholinoceptors at the motor end-plate. Read about Rocuronium

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ESMERON Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M03AC09	Rocuronium bromide	M Musculo-skeletal system → M03 Muscle relaxants → M03A Muscle relaxants, peripherally acting agents → M03AC Other quaternary ammonium compounds
Discover more medicines within M03AC09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 527316010017803
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 23.874-1-06-11
Country: EE	Ravimiamet	Identifier(s): 1040218, 1074282, 1138687, 1294321
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61141
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 095879
Country: FR	Base de données publique des médicaments	Identifier(s): 68986795
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 165869
Country: HK	Department of Health Drug Office	Identifier(s): 39066
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6270
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1015685, 1026892, 1056348
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 235M96
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 46280
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7027
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100083744, 100083810
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W63436001, W63436002, W63436003
Country: SG	Health Sciences Authority	Identifier(s): 09479P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 70131511H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699636770016, 8699636770030
Country: ZA	Health Products Regulatory Authority	Identifier(s): 30/17.1/0192, 30/17.1/0193, 34/17.1/0174